首页|平喘固本汤联合氟替美维对AECOPD住院患者血清炎症指标及血气指标的影响

平喘固本汤联合氟替美维对AECOPD住院患者血清炎症指标及血气指标的影响

扫码查看
目的:探讨平喘固本汤联合氟替美维对慢性阻塞性肺疾病急性加重期(AECOPD)住院患者血清炎症指标及血气指标的影响。方法:选取 2023年 4月—2024年 4月桂林市中西医结合医院收治的 88例AECOPD患者为研究对象,采用随机数字表法将其分为对照组及研究组,各44例。两组均接受常规治疗,在此基础上,对照组采用氟替美维治疗,研究组采用平喘固本汤联合氟替美维治疗。两组均连续治疗3 个月。比较两组肺功能、炎症指标及血气指标。结果:治疗后,研究组的最大呼气峰值流速快于对照组,第 1秒用力呼气容积高于对照组,差异均有统计学意义(P<0。05)。治疗后,研究组的白细胞介素-6、白细胞介素-8、肿瘤坏死因子-α水平均低于对照组,差异均有统计学意义(P<0。05)。治疗后,研究组的动脉血氧分压、动脉血氧饱和度均高于对照组,差异均有统计学意义(P<0。05)。结论:平喘固本汤联合氟替美维能显著改善AECOPD住院患者的肺功能,降低血清炎症指标水平,并优化血气分析结果,对疾病的控制及患者预后均有积极影响。
Effects of Pingchuan Guben Decoction Combined with Fluticasone Furoate,Umeclidinium Bromide and Vilanterol Trifenatate on Serum Inflammatory Indexes and Blood Gas Indexes in Patients with AECOPD
Objective:To investigate the effects of Pingchuan Guben Decoction combined with Fluticasone Furoate,Umeclidinium Bromide and Vilanterol Trifenatate on serum inflammatory indexes and blood gas indexes in inpatients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods:A total of 88 inpatients with AECOPD in Guilin Hospital of Integrated Traditional Chinese and Western Medicine from April 2023 to April 2024 were selected as the study objects and were divided into a control group and a study group by random number table method,with 44 cases in each group.Both groups received conventional treatment,on this basis,the control group was treated with Fluticasone Furoate,Umeclidinium Bromide and Vilanterol Trifenatate,and the study group was treated with Pingchuan Guben Decoction combined with Fluticasone Furoate,Umeclidinium Bromide and Vilanterol Trifenatate.Both groups were treated continuously for three months.The lung function,inflammation indexes and blood gas indexes were compared between the two groups.Results:After treatment,the peak expiratory flow in the study group were faster than that of the control group,and forced expiratory volume in one second was higher than that in the control group,the differences were statistically significant(P<0.05).After treatment,the levels of interleukin-6,interleukin-8 and tumor necrosis factor-α in the study group were lower than those in the control group,the differences were statistically significant(P<0.05).After treatment,the partial pressure of arterial blood oxygen and saturation of arterial blood oxygen in the study group were higher than those in the control group,the differences were statistically significant(P<0.05).Conclusion:Pingchuan Guben Decoction combined with Fluticasone Furoate,Umeclidinium Bromide and Vilanterol Trifenatate can significantly improve the lung function of patients with AECOPD,reduce the levels of serum inflammatory indicators,optimize the results of blood gas analysis,and have a positive impact on disease control and patient prognosis.

Chronic obstructive pulmonary diseaseAcute exacerbationPingchuan Guben DecoctionFluticasone Furoate,Umeclidinium Bromide and Vilanterol TrifenatateInflammationBlood gas analysis

侯冬莲

展开 >

广西壮族自治区桂林市中西医结合医院内二科,广西壮族自治区 桂林 541000

慢性阻塞性肺疾病 急性加重期 平喘固本汤 氟替美维 炎症 血气分析

2024

中国伤残医学
中国康复医学会,黑龙江省截瘫研究所

中国伤残医学

影响因子:0.451
ISSN:1673-6567
年,卷(期):2024.32(19)